Inhibition of Histone Deacetylases Potentiates BMP9-Induced Osteogenic Signaling in Mouse Mesenchymal Stem Cells
Author(s) -
Ning Hu,
Changdong Wang,
Xi Liang,
Liangjun Yin,
Xiaoji Luo,
Bo Liu,
Hongyu Zhang,
Wei Shui,
Guoxin Nan,
Ning Wang,
Ningning Wu,
Xian Chen,
Yunfeng He,
Sheng Wen,
Fang Deng,
Hongmei Zhang,
Zhan Liao,
Hue H. Luu,
Rex C. Haydon,
TongChuan He,
Wei Huang
Publication year - 2013
Publication title -
cellular physiology and biochemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.486
H-Index - 87
eISSN - 1421-9778
pISSN - 1015-8987
DOI - 10.1159/000354453
Subject(s) - mesenchymal stem cell , microbiology and biotechnology , stem cell , cancer research , signal transduction , chemistry , histone , biology , biochemistry , gene
We have demonstrated that bone morphogenetic protein 9 (BMP9) is one of the most potent BMPs in regulating osteoblast differentiation of mesenchymal stem cells (MSCs) although the molecular mechanism underlying BMP9-induced osteogenesis remains to be fully elucidated. It is known that epigenetic regulations play an important role in regulating the stem cell potency and lineage commitment. Here, we investigate if the inhibition of histone deacetylases (Hdacs) affects BMP9-induced osteogenic differentiation of MSCs.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom